Financhill
Back

Pliant Therapeutics, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison

Sell
19

PLRX
Pliant Therapeutics, Inc.

Last Price:
$1.21
Seasonality Move:
-12.32%
Buy
59

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$774.48
Seasonality Move:
12.13%
Sell
19
Pliant Therapeutics, Inc. (PLRX) is a Sell

Is Pliant Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Pliant Therapeutics, Inc. [PLRX] share price is $1.23. The Score for PLRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $780.50. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PLRX Stock Price Chart

What is Pliant Therapeutics, Inc.'s stock price today?

  • The Pliant Therapeutics, Inc. share price today is $1.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals, Inc.'s stock price today?

  • The Regeneron Pharmaceuticals, Inc. share price today is $780.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.

PLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 38.87 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.19 - 1.49) Sell
Bollinger Bands (100): (1.37 - 1.71) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 216.48 Buy
Relative Strength Index (14 RSI): 65.27 Buy
Chaikin Money Flow: 70647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (725.9 - 779.36) Buy
Bollinger Bands (100): (557.81 - 715.59) Buy

PLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Buy
20-day SMA: 1.29 Sell
50-day SMA: 1.51 Sell
200-day SMA: 1.49 Sell
8-day EMA: 1.06 Buy
20-day EMA: 0.67 Buy
50-day EMA: 0.33 Buy
200-day EMA: 0.09 Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 772.52 Buy
20-day SMA: 747.31 Buy
50-day SMA: 699.49 Buy
200-day SMA: 602.77 Buy
8-day EMA: 674.04 Buy
20-day EMA: 427.09 Buy
50-day EMA: 211.88 Buy
200-day EMA: 59.42 Buy

Pliant Therapeutics, Inc. Earnings Growth & PLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and a decrease next year of $0.00 per share.

Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and a decrease next year of $0.00 per share.

Pliant Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):